Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

IPI-926 reduces tumor growth in vivo and advances through clinical development

April 4, 2011

Superoxide dismutase [Cu-Zn] as a biomarker for drug-induced liver injury

April 4, 2011

Immunohistochemical quantitation of LAMP-2 for the diagnosis of phospholipidosis

April 4, 2011

Liver-targeted SCD inhibitor from Merck & Co. shows improved tolerability

April 1, 2011

Astellas Pharma discloses potent, orally bioavailable TRPV1 antagonists

April 1, 2011

N30 Pharma's GSNOR inhibitors show promise for the treatment of asthma

April 1, 2011

Omalizumab data in food allergy, urticaria, atopic dermatitis and geriatric asthma reported

April 1, 2011

OriBase Pharma identifies agent for BCR/ABL T315I mutant CML

March 31, 2011

New dual LFA-1/MAC-1 antagonists presented by Roche at the ACS meeting

March 31, 2011

Merck & Co. presents new glucagon receptor antagonist for type 2 diabetes

March 31, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...